A detailed history of Sg Americas Securities, LLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 51,725 shares of ENOB stock, worth $237,934. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,725
Previous 17,635 193.31%
Holding current value
$237,934
Previous $9,000 377.78%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

BUY
N/A
34,090 Added 193.31%
51,725 $43,000
Q3 2024

Oct 03, 2024

BUY
N/A
17,635 New
17,635 $9,000
Q1 2024

May 06, 2024

BUY
N/A
17,263 New
17,263 $46,000

Others Institutions Holding ENOB

About Enochian Biosciences Inc


  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.